Bioeq’s Lucentis Biosimilar Is Given EU Go-Ahead

Launch Dates And Financial Terms Of A Marketing Deal With Teva Remain Under Wraps

 
• By Rosalind Rei
  
Close-up of woman's eye, with light falling on retina
The Ranivisio ranibizumab biosimilar has been formally approved by the European Commission • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products